Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wirth

Showing results (581-590 of 675) with videos related to

Pageof 68
Sort By:
Cancer|April 16, 2018
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)Lori J Wirth, Makoto Tahara, Bruce Robinson, et al.
Headache|April 25, 2022
Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine preventionRichard B Lipton, Peter J Goadsby, David W Dodick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2015
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell CarcinomaThomas J Galloway, Lori J Wirth, Alexander D Colevas, et al.
The New England Journal of Medicine|July 4, 2008
Motesanib diphosphate in progressive differentiated thyroid cancerSteven I Sherman, Lori J Wirth, Jean-Pierre Droz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2006
Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neckRoy B Tishler, Marshall R Posner, Charles M Norris, et al.
ESMO Open|January 28, 2026
Artificial intelligence-powered real-time multimodal model for predicting recurrence and survival in head and neck cancer: a multicenter, multinational studyH A Jung, R Merkin, A L Feng, et al.
European Journal of Human Genetics : EJHG|March 27, 1999
Molecular cytogenetic detection of 9q34 breakpoints associated with nail patella syndromeA Silahtaroglu, F A Hol, P K Jensen, et al.
Headache|March 16, 2022
Impact of the COVID-19 pandemic on people living with migraine: Results of the MiCOAS qualitative studyDawn C Buse, Maya T Gerstein, Carrie R Houts, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2019
Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV modelEiichi Ishida, Jina Lee, Jean S Campbell, et al.
Human Molecular Genetics|April 4, 2001
Functional hemizygosity of PAFAH1B3 due to a PAFAH1B3-CLK2 fusion gene in a female with mental retardation, ataxia and atrophy of the brainH G Nothwang, H G Kim, J Aoki, et al.
Pageof 68

Showing results (581-590 of 675) with videos related to

Sort By:
Pageof 68
Cancer|April 16, 2018
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)Lori J Wirth, Makoto Tahara, Bruce Robinson, et al.
Headache|April 25, 2022
Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine preventionRichard B Lipton, Peter J Goadsby, David W Dodick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2015
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell CarcinomaThomas J Galloway, Lori J Wirth, Alexander D Colevas, et al.
The New England Journal of Medicine|July 4, 2008
Motesanib diphosphate in progressive differentiated thyroid cancerSteven I Sherman, Lori J Wirth, Jean-Pierre Droz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2006
Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neckRoy B Tishler, Marshall R Posner, Charles M Norris, et al.
ESMO Open|January 28, 2026
Artificial intelligence-powered real-time multimodal model for predicting recurrence and survival in head and neck cancer: a multicenter, multinational studyH A Jung, R Merkin, A L Feng, et al.
European Journal of Human Genetics : EJHG|March 27, 1999
Molecular cytogenetic detection of 9q34 breakpoints associated with nail patella syndromeA Silahtaroglu, F A Hol, P K Jensen, et al.
Headache|March 16, 2022
Impact of the COVID-19 pandemic on people living with migraine: Results of the MiCOAS qualitative studyDawn C Buse, Maya T Gerstein, Carrie R Houts, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2019
Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV modelEiichi Ishida, Jina Lee, Jean S Campbell, et al.
Human Molecular Genetics|April 4, 2001
Functional hemizygosity of PAFAH1B3 due to a PAFAH1B3-CLK2 fusion gene in a female with mental retardation, ataxia and atrophy of the brainH G Nothwang, H G Kim, J Aoki, et al.
Pageof 68